These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma.
    Author: Surwit RS, Gilgor RS, Allen LM, Duvic M.
    Journal: Arch Dermatol; 1984 Mar; 120(3):329-31. PubMed ID: 6367665.
    Abstract:
    Nineteen patients with Raynaud's phenomenon in conjunction with progressive systemic sclerosis were given either prazosin hydrochloride (1 mg orally three times a day) or a placebo for eight weeks, after which the treatment procedure was reversed for four weeks. Prazosin was shown to be effective in reducing both the frequency and the severity of vasospasm reported by the patients.
    [Abstract] [Full Text] [Related] [New Search]